Central Adelaide Local Health Network Incorporated
USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).
The verdict
According to USPTO PatentsView, Central ranks #28,374 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 7 technology areas.
- #28,374
- of 49,997 US assignees by volume
- 31st percentile
- by Innovation Score (29.4/100)
- 9.1
- avg claims per patent
- +0%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R28374 · Foreign Corporation #28,374 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MICRO 9 grants
- MID-PACK #28,374/49,997
- PHOTO-FINISH Cellino Biotech
- CPC-NARROW C12Q · 7 areas
- INNOV-THIN 29.4/100
- CLAIMS-PAR 9.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT +0% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Cellino Biotech, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Central’s 29.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Central
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Central Adelaide… · this assignee 29
Central Adelaide… · this assignee
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Central's Innovation Score is 29.4/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Central?
Each dot is one of Central’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Central’s own 9.1 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Central's grants concentrate
Central Adelaide Local Health Network Incorporated is a focused PatentsView assignee: 7 CPC subclasses with 77.8% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2018. By volume, Central sits between Cellino Biotech, Inc. and Chapman University.
Central's three-year grant acceleration
Central Adelaide Local Health Network Incorporated shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Central's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cellino Biotech
Cellino Biotech, Inc.
9 patents
- Cellsec
Cellsec, Inc.
9 patents
- Cellutech AB
Cellutech AB
9 patents
- Center Vue S p A
Center Vue S.p.A.
9 patents
- Centro de Investi…
Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV)
9 patents
- Certona
Certona Corporation
9 patents
- Changsha Sinocare
Changsha Sinocare Inc.
9 patents
- Chapman University
Chapman University
9 patents
- Central Adelaide… ◀
Central Adelaide Local Health Network Incorporated
9 patents
What this shows Central holds 9 patents at rank #28,446, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Central
By rank, the assignees closest to #28,446 in granted patent volume.
- Cellino Biotech, Inc. #28,442 · 9 patents
- Cellsec, Inc. #28,443 · 9 patents
- Cellutech AB #28,444 · 9 patents
- Center Vue S.p.A. #28,445 · 9 patents
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV) #28,447 · 9 patents
- Certona Corporation #28,448 · 9 patents
- Changsha Sinocare Inc. #28,449 · 9 patents
- Chapman University #28,450 · 9 patents
Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)
Other assignees with the most granted patents in Central's primary technology class.
- The Regents of the University of California 581 in class
- Life Technologies Corporation 546 in class
- Illumina, Inc. 445 in class
- President and Fellows of Harvard College 387 in class
- Immatics Biotechnologies GmbH 286 in class
- 10x Genomics, Inc. 282 in class
- The Board of Trustees of the Leland Stanford Junior University 266 in class
- Pacific Biosciences OF California, Inc. 259 in class
Central's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 31st percentile higher than 31% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 3 | 33.3% |
| 2018 | 1 | 11.1% |
| 2020 | 2 | 22.2% |
| 2022 | 1 | 11.1% |
| 2024 | 1 | 11.1% |
| 2025partial year | 1 | 11.1% |
Which technologies does Central Adelaide Local Health Network Incorporated patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Central Adelaide Local Health Network Incorporated's patent record in context - here's where to go next.
- Central Adelaide Local Health Network Incorporated's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 77.8% of its portfolio - see every assignee active in that class. Explore C12Q
- Ranked #28,374 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Central Adelaide Local Health Network Incorporated against Cellino Biotech, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.